van der Graaff M, Vermeulen N P, Joeres R P, Breimer D D
Drug Metab Dispos. 1983 Sep-Oct;11(5):489-93.
The enantiomers of hexobarbital (HB), designated as (+)-HB and (-)-HB, were administered orally to separate groups of rats. Blood concentration-time curves of the parent compounds and the metabolites 3'-hydroxyhexobarbital (OH-HB) and 3'-ketohexobarbital (K-HB) were determined, as well as the cumulative urinary excretion of unconjugated OH-HB, K-HB, and 1,5-dimethylbarbituric acid (DMBA). The t1/2,(+)-HB was 13.4 +/- 0.8 min, and the t1/2,(-)-HB was slightly longer, 16.7 +/- 0.6 min (mean +/- SEM, N = 6). The intrinsic clearance values, CLint,(+)-HB and CLint,(-)-HB, were 2947 +/- 358 and 411 +/- 65 ml min-1 kg-1, respectively. The extraction ratios (E) were 0.94 for (+)-HB and 0.68 for (-)-HB. The t1/2,OH-(+)-HB and t1/2,OH-(-)-HB as calculated from blood data, were nearly the same: 20.0 +/- 2.6 and 22.2 +/- 1.5 min, respectively. Such data could not be established for the K-HB metabolites, since the curves exhibited no clear elimination phase. DMBA was undetectable in blood. The cumulative excretion of the measured metabolites in 24-hr urine was 44.0 +/- 1.8% for (+)-HB and 78.9 +/- 2.9% for (-)-HB, which was predominantly due to a substantial difference in the percentage of K-HB excreted. It is concluded that, to apply HB as a model substrate to assess oxidative enzyme activity, the use of only (-)-HB should be preferred to (+)-HB or (+/-)-HB because of a lower intrinsic clearance and a more complete recovery of oxidized metabolites in urine.
将己巴比妥(HB)的对映体,即(+)-HB和(-)-HB,分别口服给予不同组的大鼠。测定了母体化合物及其代谢产物3'-羟基己巴比妥(OH-HB)和3'-酮己巴比妥(K-HB)的血药浓度-时间曲线,以及未结合的OH-HB、K-HB和1,5-二甲基巴比妥酸(DMBA)的累积尿排泄量。(+)-HB的t1/2为13.4±0.8分钟,(-)-HB的t1/2稍长,为16.7±0.6分钟(平均值±标准误,N = 6)。内在清除率值CLint,(+)-HB和CLint,(-)-HB分别为2947±358和411±65 ml min-1 kg-1。提取率(E)对于(+)-HB为0.94,对于(-)-HB为0.68。根据血液数据计算的t1/2,OH-(+)-HB和t1/2,OH-(-)-HB几乎相同:分别为20.0±2.6和22.2±1.5分钟。由于曲线未显示出明显的消除相,因此无法确定K-HB代谢产物的此类数据。血液中未检测到DMBA。(+)-HB在24小时尿液中测得的代谢产物累积排泄率为44.0±1.8%,(-)-HB为78.9±2.9%,这主要是由于K-HB排泄百分比存在显著差异。结论是,为了将HB用作评估氧化酶活性的模型底物,由于内在清除率较低且尿液中氧化代谢产物的回收率更高,因此应优先使用(-)-HB而非(+)-HB或(±)-HB。